診斷影像市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、應用、最終用途、地區和競爭格局分類），2021-2031年

全球診斷影像市場預計將從 2025 年的 281.2 億美元成長到 2031 年的 378.8 億美元，複合年成長率為 5.09%。

該領域涵蓋多種醫療技術，例如X光、磁振造影（MRI）、電腦斷層掃描（CT）和超音波，這些技術能夠可視化體內生理結構，對診斷和監測健康狀況至關重要。市場成長的主要驅動力是人口結構變化，特別是全球人口快速老化以及心血管疾病和癌症等慢性病的日益增加。這些因素使得頻繁的診斷干預和疾病早期檢測變得尤為必要，從而為市場擴張奠定了堅實的基礎，使其超越了短暫的技術趨勢。

然而，由於全球訓練有素的技術人員和放射科醫生嚴重短缺，市場面臨著巨大的擴充性障礙，這限制了醫療系統應對日益成長的檢查量的能力。這種人才短缺正在造成嚴重的瓶頸和患者照護延誤。例如，英國英國放射學院報告稱，到2024年，臨床放射科醫生將出現29%的缺口，因為對CT和MRI等複雜掃描的需求增加了8%，而顧問醫生的數量僅增加了4.7%。

市場促進因素

將人工智慧 (AI) 和機器學習 (ML) 整合到診斷成像工作流程中，正透過提高診斷準確性和營運效率，徹底改變全球診斷成像市場。這些技術透過自動化常規影像分析、最佳化掃描通訊協定以及優先審查急診病例，在緩解實驗室資源短缺方面發揮至關重要的作用。這些先進演算法的監管核准正在加速推進。根據美國食品藥物管理局(FDA) 預測，截至 2024 年 8 月，累計核准的AI 和機器學習醫療設備數量將達到 950 種，其中放射學應用佔總核准的 76%。透過簡化工作流程和縮短掃描時間，AI 的整合提高了患者吞吐量，並最大限度地發揮了現有診斷成像基礎設施的效用。

疫情過後，各國政府和私人機構加大對醫療基礎設施的投資，以應對檢測延誤併升級老舊設施，進一步推動了市場成長。公共部門正投入大量資金採購先進的診斷工具，分散醫療服務，提高醫療服務的可近性。例如，英國政府在2024年10月的秋季預算中撥款15億英鎊用於擴大診斷能力，推動引進尖端掃描器和建立新的外科中心。這些投資為主要行業參與者帶來了強勁的財務表現。 2024年11月，西門子醫療公佈其診斷影像部門的銷售額年增7.7%，凸顯了全球對先進診斷系統的持續需求。

市場挑戰

訓練有素的放射科醫生和技術人員短缺是限制全球診斷影像市場規模發展的結構性障礙。儘管慢性病盛行率的上升理論上會增加檢查量的需求，但由於缺乏專業人員，醫療機構無法將這種需求完全轉化為市場成長。如果沒有合格的人員操作和解讀結果，診斷設備就無法發揮作用，從而有效地限制了營運效率。因此，醫療機構被迫推遲新技術的應用，並將資本預算用於支付高成本的人事費用，而不是擴大診斷能力。

這種營運負擔造成了系統性效率低下，嚴重阻礙了市場發展。 2024年，英國英國放射學院指出，97%的放射科被迫依賴昂貴的外包或內部解決方案來應對難以承受的檢測結果報告工作量。這種對外部支援的過度依賴表明，現有人員配置已達到飽和點，無法支撐內部成長。由於醫療系統難以應對這些瓶頸，新增診斷影像基礎設施的採用停滯不前，直接阻礙了市場更廣泛的擴張潛力。

市場趨勢

隨著磁振造影（MRI）和電腦斷層掃描（CT）等高能耗成像方式對環境的影響日益凸顯，永續且環保的診斷影像解決方案正成為市場關注的焦點。製造商正在開發能夠最大限度降低電力消耗並減少對稀缺資源（例如用於冷卻傳統磁鐵的氦氣）依賴的系統。這種轉變正在監管和營運層面同時發生，醫療機構力求降低長期營運成本並為供應鏈波動做好準備。根據皇家飛利浦公司2025年3月發布的報告，自2018年以來，其BlueSeal磁鐵技術已累積節省超過275萬升氦氣，顯示無氦基礎設施正在迅速普及。

同時，攜帶式和照護現場設備的普及正在使診斷服務更加大眾化，並將診斷影像的應用範圍從傳統醫院擴展到各種臨床環境。半導體技術的進步使得手持式超音波設備得以開發，其體積和成本僅為傳統推車式系統的幾分之一，卻能提供高解析度影像。這一趨勢有助於在床邊進行即時診斷，縮短患者等待時間，並減輕中心放射科的負擔。 2025年5月，Butterfly Networks公佈的第一季財報顯示，其營收年增20%，這印證了全球對高度攜帶式診斷成像解決方案日益成長的需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球診斷影像市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品（X光、超音波、電腦斷層掃描、核子醫學掃描術診斷、磁振造影造影）
  • 依應用領域（腫瘤科、神經科、心臟科、婦科、整形外科等）
  • 依最終用戶（醫院、診斷影像中心、門診影像中心）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美診斷影像市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲診斷影像市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區診斷影像市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲診斷影像市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲診斷影像市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球診斷影像市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• GE HealthCare Technologies Inc.
• Koninklijke Philips NV
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote SpA
• Fujifilm Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Diagnostic Imaging Market is projected to expand from USD 28.12 Billion in 2025 to USD 37.88 Billion by 2031, reflecting a compound annual growth rate of 5.09%. This sector encompasses a variety of medical technologies, including X-ray, magnetic resonance imaging, computed tomography, and ultrasound, which are essential for visualizing internal physiological structures to diagnose and monitor health conditions. The market's growth is fundamentally driven by demographic changes, particularly a rapidly aging global population and the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. These factors necessitate frequent diagnostic interventions and early disease detection, establishing a solid foundation for market expansion that extends beyond temporary technological trends.

However, the market faces a significant scalability hurdle due to a critical global shortage of trained technicians and radiologists, which limits the capacity of healthcare systems to handle rising procedural volumes. This workforce deficit causes severe bottlenecks and delays in patient care. For instance, the Royal College of Radiologists reported in 2024 that the clinical radiology workforce operated with a 29% shortfall, as the demand for complex scans like CT and MRI increased by 8% while the consultant workforce grew by only 4.7%.

Market Driver

The integration of artificial intelligence and machine learning into imaging workflows is revolutionizing the Global Diagnostic Imaging Market by improving diagnostic accuracy and operational efficiency. These technologies are becoming essential for mitigating workforce shortages by automating routine image analysis, optimizing scan protocols, and prioritizing urgent cases for review. Regulatory approvals for these sophisticated algorithms are accelerating; according to the U.S. Food and Drug Administration, the cumulative number of authorized AI and ML-enabled medical devices reached 950 in August 2024, with radiology applications comprising 76% of these approvals. By streamlining workflows and reducing scan times, AI integration enhances patient throughput and maximizes the utility of existing imaging infrastructure.

Market growth is further propelled by increasing government and private investments in healthcare infrastructure, aimed at clearing post-pandemic backlogs and modernizing aging equipment. Public sector initiatives are allocating substantial funds to procure advanced diagnostic tools, thereby decentralizing care and improving accessibility. For example, the UK Government allocated £1.5 billion in its October 2024 Autumn Budget to expand diagnostic capabilities, including the deployment of modern scanners and the establishment of new surgical hubs. These investments are generating robust financial performance for major industry players; Siemens Healthineers reported a 7.7% comparable revenue growth for its Imaging segment in November 2024, highlighting the sustained global demand for advanced diagnostic systems.

Market Challenge

The shortage of trained radiologists and technicians presents a structural barrier that fundamentally limits the scalability of the global diagnostic imaging market. Although the rising prevalence of chronic diseases creates a theoretical demand for higher procedure volumes, healthcare providers are unable to fully convert this into market growth due to the scarcity of human expertise. Diagnostic equipment cannot generate value without qualified personnel to operate it and interpret results, effectively placing a hard ceiling on operational throughput. Consequently, facilities are often forced to delay acquiring new technologies, diverting capital budgets toward premium labor costs rather than expanding diagnostic capabilities.

This operational strain significantly impedes the market's trajectory by causing systemic inefficiencies. In 2024, the Royal College of Radiologists indicated that 97% of radiology departments were compelled to rely on expensive outsourcing or insourcing measures to manage unmanageable reporting workloads. This heavy dependence on external support suggests that the market has reached a saturation point where existing staffing levels cannot support organic growth. As healthcare systems struggle to manage these bottlenecks, the deployment of additional imaging infrastructure is stalled, directly hampering the broader expansion potential of the market.

Market Trends

The market is increasingly prioritizing sustainable and eco-friendly imaging solutions, driven by the urgent need to reduce the environmental impact of energy-intensive modalities like MRI and CT. Manufacturers are engineering systems that minimize power consumption and reduce dependency on scarce resources such as helium, which is critical for cooling conventional magnets. This shift is both regulatory and operational, as healthcare facilities seek to lower long-term running costs and protect against supply chain volatilities. According to a March 2025 report by Royal Philips, their BlueSeal magnet technology has collectively saved over 2.75 million liters of helium since 2018, illustrating the rapid adoption of helium-free infrastructure.

Simultaneously, the proliferation of portable and point-of-care devices is democratizing diagnostic access, moving imaging beyond traditional hospital suites into diverse clinical settings. Advancements in semiconductor technology have enabled the development of handheld ultrasound units that offer high-resolution imaging at a fraction of the size and cost of cart-based systems. This trend facilitates immediate bedside diagnosis, reducing patient wait times and alleviating the burden on central radiology departments. In May 2025, Butterfly Network reported a 20% year-over-year revenue growth in its first-quarter financial results, underscoring the surging global demand for agile, handheld imaging solutions.

Key Market Players

• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Hitachi High-Tech Corporation
• Hologic, Inc.
• Siemens Healthineers AG
• Samsung Medicine Co., Ltd.
• Shimadzu Corporation
• Toshiba Medical Systems Corporation
• Esaote S.p.A
• Fujifilm Corporation

Report Scope

In this report, the Global Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Imaging Market, By Product

• X-Ray
• Ultrasound
• Computed Tomography
• Nuclear Imaging
• Magnetic Resonance Imaging

Diagnostic Imaging Market, By Application

• Oncology
• Neurology
• Cardiology
• Gynecology
• Orthopedics
• Others

Diagnostic Imaging Market, By End Use

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Imaging Centers

Diagnostic Imaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Market.

Available Customizations:

Global Diagnostic Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (X-Ray, Ultrasound, Computed Tomography, Nuclear Imaging, Magnetic Resonance Imaging)
  • 5.2.2. By Application (Oncology, Neurology, Cardiology, Gynecology, Orthopedics, Others)
  • 5.2.3. By End Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Imaging Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Diagnostic Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diagnostic Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Diagnostic Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Diagnostic Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Diagnostic Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diagnostic Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Diagnostic Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Diagnostic Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Diagnostic Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Diagnostic Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Diagnostic Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Diagnostic Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Diagnostic Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Diagnostic Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Diagnostic Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Diagnostic Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Diagnostic Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Diagnostic Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Diagnostic Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Diagnostic Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Diagnostic Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Diagnostic Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Diagnostic Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Diagnostic Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Diagnostic Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GE HealthCare Technologies Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Koninklijke Philips N.V.
• 15.3. Hitachi High-Tech Corporation
• 15.4. Hologic, Inc.
• 15.5. Siemens Healthineers AG
• 15.6. Samsung Medicine Co., Ltd.
• 15.7. Shimadzu Corporation
• 15.8. Toshiba Medical Systems Corporation
• 15.9. Esaote S.p.A
• 15.10. Fujifilm Corporation

16. Strategic Recommendations

17. About Us & Disclaimer